# Criteria for Selecting First-line Metastatic Treatment for Patients With Urothelial Carcinoma

> **NCT07339878** · — · RECRUITING · sponsor: **University Hospital, Strasbourg, France** · enrollment: 50 (estimated)

## Conditions studied

- Metastatic Urothelial Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07339878
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-20
- **Primary completion:** 2026-04
- **Final completion:** 2026-04-20
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07339878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07339878, "Criteria for Selecting First-line Metastatic Treatment for Patients With Urothelial Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07339878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*